International Journal of Clinical Research

Objective To analyze the efficacy evaluation of budesonide combined with interferon nebulization inhalation in the treatment of viral pneumonia in children. Methods Select 50 children with viral pneumonia treated in our pediatric department from January 2022 to June 2022, during which they will receive routine treatment and serve as the control group; Select 50 children with viral pneumonia treated in our pediatric department from July 2022 to January 2023. During this period, they will be treated with budesonide combined with interferon nebulization inhalation as the observation group. Results The recovery time and treatment time of lung function in the observation group were both shorter than those in the control group; The satisfaction of the families of the children in the observation group was higher than that in the control group; The relief time of various symptoms in the observation group was shorter than that in the control group; The differences were statistically significant (P<0.05). Conclusion The implementation of budesonide combined with interferon nebulization inhalation therapy in children with viral pneumonia has achieved significant results.

Budesonide; Interferon nebulization inhalation; Childhood viral pneumonia; Efficacy evaluation